Eesti - eesti - Ravimiamet

dne pharma as - naloksoon - ninasprei, lahus üheannuselises konteineris - 1,26mg 0.1ml 0.1ml 20tk; 1,26mg 0.1ml 0.1ml 2tk

Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - paratsetamool - suukaudne suspensioon - 40mg 1ml 85ml 1tk

Eesti - eesti - Ravimiamet

dr. august wolff gmbh & co. kg arzneimittel - metronidasool - vaginaalsuposiit - 1g 2tk

Eesti - eesti - Ravimiamet

vetviva richter gmbh - asaperoon - süstelahus - 40mg 1ml 50ml 1tk

Eesti - eesti - Ravimiamet

ecuphar veterinaria s.l.u. - etamsülaat - süstelahus - 125mg 1ml 20ml 10tk; 125mg 1ml 20ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - sigalaste immunoloogilised omadused - sead - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Eesti - eesti - Ravimiamet

livisto int'l s.l. - amoksitsilliin+klavulaanhape - tablett - 250mg+62,5mg 50tk; 250mg+62,5mg 100tk; 250mg+62,5mg 250tk; 250mg+62,5mg 30tk

Eesti - eesti - Ravimiamet

livisto int'l s.l. - amoksitsilliin+klavulaanhape - tablett - 50mg+12,5mg 50tk; 50mg+12,5mg 10tk; 50mg+12,5mg 250tk; 50mg+12,5mg 100tk; 50mg+12,5mg 30tk

Eesti - eesti - Ravimiamet

livisto int'l s.l. - amoksitsilliin+klavulaanhape - tablett - 500mg+125mg 30tk; 500mg+125mg 10tk; 500mg+125mg 50tk; 500mg+125mg 100tk; 500mg+125mg 250tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - sead - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.